Randomised controlled study of early use of inhaled corticosteroid in preterm infants with respiratory distress syndrome

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 80, Issue 3, 1999, Pages

  Fok, T F ^a,b   Lam, K ^a,b   Dolovich, M ^a,b   Ng, P C ^a,b   Wong, W ^a,b   Cheung, K L ^a,b   So, K W ^a,b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Aerosol; Corticosteroid; Fluticasone propionate; Mechanical ventilation; Respiratory distress syndrome

Indexed keywords

FLUTICASONE PROPIONATE; LUNG SURFACTANT;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DOSE TIME EFFECT RELATION; DRUG EFFICACY; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; METERED DOSE INHALER; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0032851866     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/fn.80.3.F203     Document Type: Article

References (35)

1. Merritt TA, Cochrane CG, Holcomb K, Bohl B, Hallman M, Strayer D. Elastase and alpha 1-proteinase inhibitor activity in trachéal aspirate during respiratroy distress syndrome. JClin Invest 1983;72:656-62.
2. Murch SH, MacDonald TT, Vwood CB, Costeloe KL. Tumour necrosis factor in the bronchoalveolar secretions of infants with the respiratory distress syndrome and the effect of dexamethasone treatment. Tliorax 1992;47:44-7.
3. Yeh TF, Torre JA, Rastogi A, Anyebuno MA, Pildes RS. Early postnatal dexamethasone therapy in premature infants with severe respiratory distress syndrome: a double blind controlled study. Pediatrics I990;I17:273-82.
4. Yeh TF, Lin YJ, Hsieh WS, et at. Early postnatal dexamethasone therapy for the prevention of chronic lung disease in preterm infants with respiratory distress syndrome: a multicenter clinical trial. Pediatrics 1997;100:e3
5. Shinwell ES, Karplus M, Zmora E. Failure of early postnatal dexamethasone to prevent chronic lung disease in infants with respiratory distress syndrome. Arch Dis Child 1996; 74:F33-F7.
6. Yeh TF, Lin YJ, Huang CC, et al. Early dexamethasone therapy in preterm infants: a follow-up study. Pediatrics 1998;101:e7.
7. Papile L-A, Tyson JE, Stoll BJ, et al. A multkenter trial of two dexamethasone regimens in ventilator-dependent premature infants. N Engl J Ated 1998;338:1112-8.
8. LaForce WR, Brudno DS. Controlled trial of beclomethasone dipropionate by nebulization in oxygen- and ventilator-dependent infants. J Pediatr 1993;122:285-8.
9. Cloutier MM. Nebulized steroid therapy in bronchopulmonary dysplasia. Pediatr Pulmonol 1993;15:111-6.
10. Dunn M, Magnani L, Anaka R, Kirpalani H. Nebulized steroids for bronchopulmonary dysplasia (BPD) - a randomized, double-blind cross-over study. Pediatr Res 1991;201A.
11. Dunn MS, Magnani L, Belaide M. Inhaled corticosteroids in severe bronchopulmonary dysplasia (BPD). Pediatr Res 1989;2S:213A.
12. Yuksel B, Greenough A. Randomised trial of inhaled steroids in preterm infants with respiratory symptoms at follow up. Thorax 1992;47:910-3.
13. Giep T, Raibble P, Zuerlein T, Schwartz ID. Trial of beclomethasone dipropionate by metered-dose inhaler in ventilator-dependent neonates less than 1500 grams. AmJ Perinatal 1996;13:5-9.
14. Fok TF, Lam K, Chan CK, et al. Aerosol delivery to non-ventilated infants by metered-dose inhaler: should a valved spacer be used? Pediatr Pulmonol 1997;24:204-12.
15. Cornblath Al, Schwartz R. Disorders of carbohydrate metabolism in infancy. 2nd edn. Philadelphia: WB Saunders, 1976.
16. LJeberman J. Clinical Pediatrie Nephrology. Philadelphia: JB Uppincott, 1976.
17. Le Souëf PN, England SJ, Bryan AC. Passive respiratory mechanics in newborns and children. Am Rev Respir Dis 1984;129:553-6.
18. Jones R, Wincott E, Elbourne D, Grant A. Controlled trial of dexamethasone in neonatal chronic lung disease: a 3-year follow-up. Pediatrics 1995;96:897-906.
19. Le Souëf PN, England SJ, Bryan AC. Passive respiratory mechanics in newborns and children. Am Rev Respir Dis 1984;129:553-6.
20. Avery GB, Fletcher AB, Kaplan M, Brudno DS. Controlled trial of dexamethasone in respirator-dependent infants with bronchopulmonary dysplasia. Pediatrics 1985;75:106-11.
21. Mammel MC, Fiterman C, Coleman M, Boros SJ. Short-term dexamethasone therapy for bronchopulmonary dysplasia: acute effects and a 1-year follow-up. Dc.ii Pharmacol Ther 1987; 10:1-11.
22. Cummings JJ, D'Eugenio DB, Gross SJ. A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia. N Eng! J Med 1989;320:1505-10.
23. Ng PC. The effectiveness and side effects of dexamethasone in preterm infants with bronchopulmonary dysplasia. Arch DuCM/1993;6S:330-6.
24. Ng PC, Thomson MA, Dear PRF. Dexamethasone and infection in preterm babies: a controlled study. Arch Dis Child 1990;65:54-8.
25. Weichsel ME The therapeutic use of glucocorticoid hormones in the perinatal period: potential neurologic hazards. Ann Keurol 1977;2:364-6.
26. Cotterrell M, Balazs R, Johnson AL. Effects of corticosteroid on the biochemical maturation of rat brain: postnatal cell formation. J Neurochem 1972;19:2151-67.
27. O'Shea TM, Kothadia JM, Klinepeter KL, Goldstein DJ, Jackson B, Dillard RG. Follow-up of preterm infants treated with dexamethasone for chronic lung disease. AmJ Dis Child 1993; 147:658-61.
28. Fok TF, Dolovich M, Gray S, et al. Efficiency of aerosol medication delivery from a metered dose inhaler versus jet nebuliser in infants with bronchopulmonary dysplasia. PfJi'air Piilmono! 1996;21:301-9.
29. Fok TF, Al-essa M, Monkman S, et al. Pulmonary deposition of albuterol aerosol delivered by metered-dose inhaler, jet nebulizer and ultrasonic nebulizer in mechanicall ventilated rabbits. Pediatr Res 1997;42:721-7.
30. O'Callaghan C, Hardy J, Stammers J, Stephenson TJ, Hull D. Evaluation of techniques for delivery of steroids to lungs of neonates using a rabbit model. Arch Dis Child I992;67:20-4.
31. Rozycki HJ, Bryon PR, Dailey K, Gutcher GR. Evaluation of a system for the delivry of inhaled beclomethasone dipropionate to intubated neonates. Pediatrics 1994;S1:607-706.
32. Kamada AK, Szefler SJ. Inhaled therapy in infants: why not nebulize glucocorticoids? Pediatr Pulmonol 1992;I3:198-9.
33. Dahl R, Lundback B, Malo JL, et al. A dose-ranging study of fluticasone propionate in adult patients with moderate asthma. International Study Group. Chest 1993;104:1352-8.
34. Barnes NC, Marone G, Di Maria GU, Visser S, Utama I, Payne SL. A comparison of fluticasone propionate, 1 mg daily, with beclomethasone dipropionate, 2 mg daily, in the treatment of severe asthma. International Study Group EurRespirJ 1993;6:877-85.
35. Ng PC, Fok TF, Wbng GwK, et al. Pituitary-adrenal suppression in preterm, very low birth weight infants after inhaled fluticasone propionate treatment. J Clin Endocrinol Mctab 1998;83:2390-3.